HWM
IRMD icon

HighMark Wealth Management’s iRadimed IRMD Stock Holding History

HighMark Wealth Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-565
Closed -$22.2K – 599
2023
Q1 		$22.2K Buy
565
+15
+3% +$545 0.02% 198
2022
Q4 		$15.6K Hold
550
– – 0.01% 193
2022
Q3 		$17K Hold
550
– – 0.01% 178
2022
Q2 		$19K Buy
550
+200
+57% +$7.17K 0.02% 167
2022
Q1 		$16K Buy
+350
New +$16.2K 0.01% 202

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighMark Wealth Management's IRMD Position: Q2 2023 in Review

HighMark Wealth Management sold out of iRadimed (IRMD) in Q2 2023, closing a stake of 565 shares — an estimated $22.2K sold.

HighMark Wealth Management first reported a position in IRMD in Q1 2022 and held it in 5 quarters. The position peaked at $22.2K in Q1 2023. 112 funds tracked by Wall St. Rank hold IRMD as of Q2 2023.

  • HighMark Wealth Management reported no remaining iRadimed position as of Q2 2023 after selling out during the quarter.
  • HighMark Wealth Management sold 565 iRadimed shares in Q2 2023, an estimated $22.2K.
  • HighMark Wealth Management first reported a position in iRadimed in Q1 2022 and held it in 5 quarters.
  • HighMark Wealth Management's iRadimed position peaked at $22.2K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held iRadimed as of Q2 2023.

Based on HighMark Wealth Management's 13F filing for Q2 2023, filed 26 Jul 2023.